Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates

Pediatric Research

Volumn 75, Issue 1-2, 2014, Pages 241-250

  Ment, Laura R ^a   Ådén, Ulrika ^b   Lin, Aiping ^a   Kwon, Soo Hyun ^a   Choi, Murim ^a   Hallman, Mikko ^c   Lifton, Richard P ^a   Zhang, Heping ^a   Bauer, Charles R ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANNEXIN; ANNEXIN 7; ARACHIDONIC ACID; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; CD51 ANTIGEN; CELL SURFACE RECEPTOR; COLLAGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 4A1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOOXYGENASE 2; DEATH RECEPTOR 6; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELIN BASIC PROTEIN; PROTHROMBIN; TIGHT JUNCTION PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; BLOOD CLOTTING FACTOR; COLLAGEN 4A1; STRUCTURAL PROTEIN;

APGAR SCORE; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; DELIVERY; DIET RESTRICTION; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MATERNAL NUTRITION; NONHUMAN; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; BRAIN INJURY; DISEASE SEVERITY; GENE; GENOME; INFLAMMATION; NEWBORN; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; APGAR SCORE; BLOOD COAGULATION; CEREBRAL VENTRICLES; CEREBROVASCULAR CIRCULATION; COLLAGEN TYPE IV; FACTOR V; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GESTATIONAL AGE; HUMANS; HYPOXIA, BRAIN; INFANT; INFANT, PREMATURE; INFLAMMATION MEDIATORS; INTRACRANIAL HEMORRHAGES; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PHENOTYPE; PREMATURE BIRTH; PROGNOSIS; RISK FACTORS;

EID: 84900451853     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.195     Document Type: Review

References (87)

1. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
2. Nongena P, Ederies A, Azzopardi DV, Edwards AD. Confidence in the prediction of neurodevelopmental outcome by cranial ultrasound and MRI in preterm infants. Arch Dis Child Fetal Neonatal Ed 2010;95:F388-90.
3. Beaino G, Khoshnood B, Kaminski M, et al.; EPIPAGE Study Group. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 2010;52:e119-25.
4. Luu TM, Ment L, Allan W, Schneider K, Vohr BR. Executive and memory function in adolescents born very preterm. Pediatrics 2011;127:e639-46.
5. Whitaker AH, Feldman JF, Lorenz JM, et al. Neonatal head ultrasound abnormalities in preterm infants and adolescent psychiatric disorders. Arch Gen Psychiatry 2011;68:742-52.
6. Hallman M. Premature birth and diseases in premature infants: common genetic background? J Matern Fetal Neonatal Med 2012;25 (Suppl 1):21-4.
7. Mohamed S, Schaa K, Cooper ME, et al. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res 2009;65:193-7.
8. Stoll BJ, Hansen NI, Bell EF, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56.
9. Mohamed MA, Aly H. Transport of premature infants is associated with increased risk for intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 2010;95:F403-7.
10. Perlman JM, Wyllie J, Kattwinkel J, et al.; Neonatal Resuscitation Chapter Collaborators. Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010;122(Suppl 2):S516-38.
11. Sweet DG, Carnielli V, Greisen G, et al.; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update. Neonatology 2010;97:402-17.
12. Hack M, Wright LL, Shankaran S, et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Network, November 1989 to October 1990. Am J Obstet Gynecol 1995;172(2 Pt 1):457-64.
13. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110-24.
14. Shalak L, Perlman JM. Hemorrhagic-ischemic cerebral injury in the preterm infant: current concepts. Clin Perinatol 2002;29:745-63.
15. Kent AL, Wright IM, Abdel-Latif ME; New South Wales and Australian Capital Territory Neonatal Intensive Care Units Audit Group. Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 2012;129:124-31.
16. Bhandari V, Bizzarro MJ, Shetty A, et al.; Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-6.
17. Harteman JC, Groenendaal F, van Haastert IC, et al. Atypical timing and presentation of periventricular haemorrhagic infarction in preterm infants: the role of thrombophilia. Dev Med Child Neurol 2012;54:140-7.
18. Ryckman KK, Dagle JM, Kelsey K, Momany AM, Murray JC. Replication of genetic associations in the inflammation, complement, and coagulation pathways with intraventricular hemorrhage in LBW preterm neonates. Pediatr Res 2011;70:90-5.
19. Baier RJ. Genetics of perinatal brain injury in the preterm infant. Front Biosci 2006;11:1371-87.
20. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1-8.
21. Bird A. Perceptions of epigenetics. Nature 2007;447:396-8.
22. Hambleton G, Wigglesworth JS. Origin of intraventricular haemorrhage in the preterm infant. Arch Dis Child 1976;51:651-9.
23. Davis EF, Newton L, Lewandowski AJ, et al. Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci 2012;123:53-72.
24. Torrens C, Brawley L, Anthony FW, et al. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension 2006;47:982-7.
25. Shirodkar AV, Marsden PA. Epigenetics in cardiovascular disease. Curr Opin Cardiol 2011;26:209-15.
26. Rexhaj E, Bloch J, Jayet PY, et al. Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms. Am J Physiol Heart Circ Physiol 2011;301:H247-52.
27. van Eijk KR, de Jong S, Boks MP, et al. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics 2012;13:636.
28. Trollmann R, Gassmann M. The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain. Brain Dev 2009;31:503-9.
29. Chow J, Ogunshola O, Fan SY, Li Y, Ment LR, Madri JA. Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res Dev Brain Res 2001;130:123-32.
30. Fish JE, Yan MS, Matouk CC, et al. Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 2010;285:810-26.
31. Yang Q, Lu Z, Ramchandran R, Longo LD, Raj JU. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation. Am J Physiol Lung Cell Mol Physiol 2012;303:L1001-10.
32. Gadek-Michalska A, Tadeusz J, Rachwalska P, Spyrka J, Bugajski J. Brain nitric oxide synthases in the interleukin-1.-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol Rep 2012;64:1455-65.
33. Machon RA, Mednick SA, Huttunen MO. Adult major affective disorder after prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1997;54:322-8.
34. Vieira-Filho LD, Lara LS, Silva PA, et al. Placental oxidative stress in malnourished rats and changes in kidney proximal tubule sodium ATPases in offspring. Clin Exp Pharmacol Physiol 2009;36:1157-63.
35. Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-96.
36. Nguyen HL, Lee YJ, Shin J, et al. TGF-. signaling in endothelial cells, but not neuroepithelial cells, is essential for cerebral vascular development. Lab Invest 2011;91:1554-63.
37. McCarty JH, Lacy-Hulbert A, Charest A, et al. Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development 2005;132:165-76.
38. Srivastava M, Atwater I, Glasman M, et al. Defects in inositol 1,4,5-trisphosphate receptor expression, Ca(2+) signaling, and insulin secretion in the anx7(+/-) knockout mouse. Proc Natl Acad Sci USA 1999;96:13783-8.
39. Tanaka Y, Naruse I, Hongo T, et al. Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech Dev 2000;95:133-45.
40. Tam SJ, Richmond DL, Kaminker JS, et al. Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 2012;22:403-17.
41. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999;401:670-7.
42. Zhu J, Motejlek K, Wang D, Zang K, Schmidt A, Reichardt LF. beta8 integrins are required for vascular morphogenesis in mouse embryos. Development 2002;129:2891-903.
43. Tran-Fadulu V, Pannu H, Kim DH, et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009;46:607-13.
44. Spyropoulos DD, Pharr PN, Lavenburg KR, et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000;20:5643-52.
45. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001;20:8334-41.
46. Asano Y, Stawski L, Hant F, et al. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 2010;176:1983-98.
47. Chabrier S, Husson B, Dinomais M, Landrieu P, Nguyen The Tich S. New insights (and new interrogations) in perinatal arterial ischemic stroke. Thromb Res 2011;127:13-22.
48. Gopel W, Gortner L, Kohlmann T, Schultz C, Moller J. Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatr 2001;90:1021-4.
49. Olie V, Zhu T, Martinez I, Scarabin PY, Emmerich J. Sex-specific risk factors for recurrent venous thromboembolism. Thromb Res 2012;130:16-20.
50. Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis 2011;216:461-6.
51. Stuart S, Cox HC, Lea RA, Griffiths LR. The role of the MTHFR gene in migraine. Headache 2012;52:515-20.
52. Dodelson de Kremer R, Grosso C. Maternal mutation 677C T in the methylenetetrahydrofolate reductase gene associated with severe brain injury in offspring. Clin Genet 2005;67:69-80.
53. Harteman JC, Groenendaal F, Benders MJ, Huisman A, Blom HJ, de Vries LS. Role of thrombophilic factors in full-term infants with neonatal encephalopathy. Pediatr Res 2013;73:80-6.
54. Refsum H, Grindflek AW, Ueland PM, et al. Screening for serum total homocysteine in newborn children. Clin Chem 2004;50:1769-84.
55. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C-T variant. Am J Obstet Gynecol 2002;186:499-503.
56. Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates. J Pediatr 2011;158(Suppl):e35-9.
57. Chawla RK, Watson WH, Jones DP. Effect of hypoxia on hepatic DNA methylation and tRNA methyltransferase in rat: similarities to effects of methyl-deficient diets. J Cell Biochem 1996;61:72-80.
58. Ito K, Miwa N, Hagiwara K, et al. Regulation of methionine adenosyltransferase activity by the glutathione level in rat liver during ischemia-reperfusion. Surg Today 1999;29:1053-8.
59. Blaise S, Alberto JM, Nedelec E, et al. Mild neonatal hypoxia exacerbates the effects of vitamin-deficient diet on homocysteine metabolism in rats. Pediatr Res 2005;57:777-82.
60. Aden U, Lin A, Carlo W, et al.; Gene Targets for Intraventricular Hemorrhage Study Group. Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm neonates. J Pediatr 2013;163:1503-1506.e1.
61. Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Neurology of the Newborn, 5 edn. Philadelphia, PA: Saunders Elsevier; 2008:517-88.
62. Chen X, Threlkeld SW, Cummings EE, et al. Ischemia-reperfusion impairs blood-brain barrier function and alters tight junction protein expression in the ovine fetus. Neuroscience 2012;226:89-100.
63. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011;130:226-38.
64. Aden U, Favrais G, Plaisant F, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010;24:747-58.
65. Sadowska GB, Threlkeld SW, Flangini A, Sharma S, Stonestreet BS. Ontogeny and the effects of in utero brain ischemia on interleukin-1. and interleukin-6 protein expression in ovine cerebral cortex and white matter. Int J Dev Neurosci 2012;30:457-63.
66. Fan LW, Tien LT, Zheng B, Pang Y, Rhodes PG, Cai Z. Interleukin- 1betainduced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by alpha-phenyl-n-tert-butyl-nitrone. Neuroscience 2010;168:240-52.
67. Ma Y, Matsuwaki T, Yamanouchi K, Nishihara M. Cyclooxygenase-2-related signaling in the hypothalamus plays differential roles in response to various acute stresses. Brain Res 2013;1508:23-33.
68. Cai Z, Pan ZL, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64-72.
69. Bilbo SD, Biedenkapp JC, Der-Avakian A, Watkins LR, Rudy JW, Maier SF. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci 2005;25:8000-9.
70. Leviton A, Allred EN, Dammann O, et al. Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol 2012; e-pub ahead of print 30 October 2012.
71. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-803.
72. Wu YW, Croen LA, Torres AR, Van De Water J, Grether JK, Hsu NN. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009;66:663-70.
73. Girotti M, Donegan JJ, Morilak DA. Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 2013;38:1158-69.
74. Harding D, Brull D, Humphries SE, Whitelaw A, Montgomery H, Marlow N. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr Res 2005;58:117-20.
75. Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha-308, MCP-1-2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 2003;4:420-6.
76. de Vries LS, Koopman C, Groenendaal F, et al. COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage. Ann Neurol 2009;65:12-8.
77. de Vries LS, Mancini GM. Intracerebral hemorrhage and COL4A1 and COL4A2 mutations, from fetal life into adulthood. Ann Neurol 2012;71:439-41.
78. Weng YC, Sonni A, Labelle-Dumais C, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012;71:470-7.
79. Bilguvar K, DiLuna ML, Bizzarro MJ, et al.; Pacifier and Breastfeeding Trial Group. COL4A1 mutation in preterm intraventricular hemorrhage. J Pediatr 2009;155:743-5.
80. Ko NU, Rajendran P, Kim H, et al. Endothelial nitric oxide synthase polymorphism (-786T-C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008;39:1103-8.
81. Vannemreddy P, Notarianni C, Yanamandra K, Napper D, Bocchini J. Is an endothelial nitric oxide synthase gene mutation a risk factor in the origin of intraventricular hemorrhage? Neurosurg Focus 2010;28:E11.
82. Poggi C, Giusti B, Vestri A, Pasquini E, Abbate R, Dani C. Genetic polymorphisms of antioxidant enzymes in preterm infants. J Matern Fetal Neonatal Med 2012;25(Suppl 4):131-4.
83. Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013;381:125-32.
84. Farooq F, Abadia-Molina F, MacKenzie D, et al. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation. Hum Mol Genet 2013;22:3415-24.
85. Liew WK, Kang PB. Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy. Ther Adv Neurol Disord 2013;6:147-60.
86. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med 2013;15:258-67.
87. Bauer SC, Msall ME. Optimizing neurodevelopmental outcomes after prematurity: lessons in neuroprotection and early intervention. Minerva Pediatr 2010;62:485-97.